Mutant CARD10 in a family with progressive immunodeficiency and autoimmunity
Mutant CARD10 in a family with progressive immunodeficiency and autoimmunity
复制标题
患有进行性免疫缺陷和自身免疫的家族中的 CARD10 突变
DOI:
10.1038/s41423-020-0423-x
复制
发表时间:
2020
影响因子:
24.1
通讯作者:
Luo Hong
中科院分区:
文献类型:
--
作者:
Yang Dan-hui;Guo Ting;Yuan Zhuang-zhuang;Lei Cheng;Ding Shui-zi;Yang Yi-feng;Tan Zhi-ping;Luo Hong
Autoimmunity and immunodeficiency were previously considered to be mutually exclusive conditions. However, an increased understanding of the complex immune regulatory systems and signaling mechanisms, coupled with the application of genetic analysis, has demonstrated the complex relationships between the two kinds of diseases. 1 In recent years, several mild forms of primary immunodeficiencies have been discovered, presenting with opportunistic infections overlapping autoimmunity and/or allergy late in life. 1Caspase recruitment domain (CARD)-containing proteins, CARD9, CARD10 (CARMA3), CARD11 (CARMA1), and CARD14 (CARMA2), are members of the membrane-associated guanylate kinase family. These proteins function as molecular scaffolds by forming an intracellular complex with B-cell lymphoma protein 10 (BCL10) and mucosa-associated lymphoid tissue lymphoma translocation gene 1 (MALT1), which are critical for the activation of several signaling pathways, such as the nuclear factor binding near the κ light chain gene in B cells (NF-κB), c-Jun N-terminal kinase, and mammalian target of rapamycin pathways, during adaptive immunity. 2, 3 In addition, dominant or recessive mutations in the CARD9, CARD11, and CARD14 genes have been identified as genetic causes of immunodeficiencies in the presence/absence of autoimmune diseases and tumors in patients and families. 4-6